Effectiveness of antistaphylococcal gamma globulin in treatment of infectious complications of acute leukemia
Faĭnshteĭn, F.E.; Golosova, T.V.; Martynova, V.A.; Abakumov, E.M.; Kovaleva, L.G.
Terapevticheskii Arkhiv 47(6): 75-79
1975
ISSN/ISBN: 0040-3660 PMID: 52893 Document Number: 86643
Document emailed within 1 workday
Related Documents
Golosova, T.V.; Anikina, T.P.; Zakhar'evskaia, N.S. 1974: Antistaphylococcal gamma globulin in complex treatment of suppurative-inflammatory staphylococcal diseases Klinicheskaia Meditsina 52(6): 115-120Spotarenko, S.S.; Karon, B.I.; Svechkin, V.N.; Luneva, E.I. 1970: The epidemiologic effectiveness of different doses of gamma-globulin in infectious hepatitis. Ii Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 47(12): 119-124
Teshima, H.; Kanakura, Y.; Ishihara, K.; Soma, T.; Hirayama, F.; Kubota, Y.; Kojima, K.; Ueda, T.; Tsubakio, T.; Nakamura, H. 1985: Infectious complications and infection prevention in patients with acute leukemia Gan no Rinsho. Japan Journal of Cancer Clinics 31(9 Suppl): 1211-1217
Alkan, W.; Eshchar, J. 1971: Gamma-globulin in prevention of infectious hepatitis Harefuah 80(12): 663-664
Nürnberger, W.; Willers, R.; Körholz, D.; Göbel, U.; Wahn, V. 1988: Preventive long-term intravenous immunoglobulin infusion in children with acute lymphatic leukemia. I. Anticomplementary activity of gamma globulin preparations is a function of the preparation and IgG concentration prior to infusions Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 136(3): 116-120
Gol'zand, I.V.; Rodionovskaia, T.F.; Tarasova, G.G.; Kulakova, M.N.; Nevskaia, E.N.; Savel'eva, V.V. 1970: Effect of gamma-globulin prophylaxis on the incidence of infectious hepatitis in children Voprosy Okhrany Materinstva i Detstva 15(6): 39-42
Barandun, S.; Skvaril, F.; Morell, A. 1976: Prophylaxis and therapy with gamma globulin. General characterization and clinical use of gamma globulin preparations Schweizerische Medizinische Wochenschrift 106(16): 533-542
Latenko, I.P.; Ziva, V.K. 1975: Use of gamma globulin for the prevention of complications in viral hepatitis Vrachebnoe Delo 1975(2): 148-150
Podsedlovskiĭ, T.S.; Dul'kene, E.A. 1973: Long-term observations on the level of collective immunity against infectious hepatitis after preventive use of gamma globulin Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 50(11): 121-124
Neguţ, E.; Litarczek, G.; Ghidaly, M.; Alexianu, D.; Dumitrescu, A.; Herlod, A.; Szégli, G. 1984: Clinical data on the use of intravenously administered gamma globulin produced by the Castacuzino Institute in different diseases of infectious etiology Revista de Igiena Bacteriologie Virusologie Parazitologie Epidemiologie Pneumoftiziologie. Bacteriologia Virusologia Parazitologia Epidemiologia 29(4): 317-324
Blau, H.J. 1972: Changes in the total serum levels of gamma globulin and immunoglobulins G, A and M in children with leukemia. 3. Discussion of the results Folia Haematologica 97(3): 157-167
Cetkovský, P.; Koza, V.; Cepelák, V.; Vít, L. 1994: Hemostasis in patients with acute leukemia treated with high doses of cytosine-arabinoside: the effect of chemotherapy and infectious complications on hemostasis Vnitrni Lekarstvi 40(11): 730-734
Migunov, V.N.; Pozina, I.M.; Liakhova, T.D.; Stavitskaia, N.K.; Smirnova, V.A. 1985: Effectiveness of treating the specimens containing hepatitis B surface antigen with cold ethanol by the Cohn method during preparation of gamma globulin Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 9: 116-117
Nordmann, P.; Schaffner, A.; Dazzi, H. 2000: Cost effectiveness in treatment of acute myeloid leukemia Schweizerische Medizinische Wochenschrift 130(51-52): 1994-2000
Martin du Pan, R.E.; Koechli, B.; Martin du Pan, R.C. 1988: Concerning "The effect of i.v. gamma globulin on T lymphocytes and on interleukin-2 secretionin infectious mononucleosis" by R.E. Martin du Pan, B. Koechli and R.C. Martin du Pan, Schweiz. med. Wschr. 1988; 118: 680-686 Schweizerische Medizinische Wochenschrift 118(51): 1962-1964
Fainshteĭn, R.E.; Kovaleva, L.G.; Levitin, E.I.; Isaev, V.G.; Abakumov, E.M. 1977: Survival of patients with acute leukemia as a criterion of the effectiveness of treatment Problemy Gematologii i Perelivaniia Krovi 22(5): 3-8
Dłuzniewska, A.; Balwierz, W.; Balcerska, A.; Chybicka, A.; Kamieńska, E.; Karolczyk, G.; Karpińska-Derda, I.; Krawczuk-Rybak, M.; Kowalczyk, J.R.; Lewandowska, D.; Maciejka-Kapuścińska, L.; Kołtano, S.; Malinowska, I.; Matysiak, Mł.; Mikołajczyk, M.; Mizia-Malarz, A.; Muszyńska-Rosłan, K.; Niedźwiedzki, M.; Pohorecka, J.; Sikorska-Fic, B.; Sobol, G.; Sońta-Jakimczyk, D.; Tomaszewska, R.; Urasiński, T.; Wachowiak, J.; Wieczorek, M.; Wójcik, B.; Wysocki, M. 2010: Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia Przeglad Lekarski 67(6): 366-370
Bauters, F.; Mouton, J.; Delmas-Marsalet, Y.; Goudemand, M. 1973: Metabolic complications of the treatment of acute leukemia with L-asparaginase (apropos of 147 cases) Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 18(10): 1207-1214 Passim
Najmowicz-Dabrowa, H. 1974: Serious infectious complications of chronic lymphatic leukemia Wiadomosci Lekarskie 27(19): 1743-1746
Morrison, V.A. 1998: The infectious complications of chronic lymphocytic leukemia Seminars in Oncology 25(1): 98-106